Literature DB >> 19705300

Cholangiocarcinoma in primary sclerosing cholangitis.

Ghulam Abbas1, Keith D Lindor.   

Abstract

INTRODUCTION: Cholangiocarcinoma (CCA) is an aggressive and nearly always fatal tumor of the biliary tract.
PURPOSE: This review explores risk factors, epidemiology, current diagnostic approaches, and treatment of CCA arising in patients with primary sclerosing cholangitis (PSC).
METHODS: We review latest recommendations about screening strategies to enable the early detection of CCA in PSC, using CA 19-9 and ultrasound imaging, as well as fluorescent in situ hybridization techniques to enhance the accuracy of biliary cytology. We also review the emerging role of liver transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19705300     DOI: 10.1007/s12029-009-9085-8

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  72 in total

1.  A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma.

Authors:  Wichuda Bamrungphon; Nalinee Prempracha; Nophawan Bunchu; Samreung Rangdaeng; Trichak Sandhu; Songphol Srisukho; Chanchai Boonla; Sopit Wongkham
Journal:  Cancer Lett       Date:  2006-06-21       Impact factor: 8.679

2.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

3.  Cholangiocarcinoma complicating primary sclerosing cholangitis.

Authors:  C B Rosen; D M Nagorney; R H Wiesner; R J Coffey; N F LaRusso
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

Review 4.  Review of gemcitabine in biliary tract carcinoma.

Authors:  Werner Scheithauer
Journal:  Semin Oncol       Date:  2002-12       Impact factor: 4.929

5.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

6.  Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma.

Authors:  Myung Ah Lee; In Sook Woo; Jin-Hyoung Kang; Young Seon Hong; Kyung Shik Lee
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-28       Impact factor: 4.553

7.  Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.

Authors:  Sharon L Swierczynski; Anirban Maitra; Susan C Abraham; Christine A Iacobuzio-Donahue; Raheela Ashfaq; John L Cameron; Richard D Schulick; Charles J Yeo; Ayman Rahman; David A Hinkle; Ralph H Hruban; Pedram Argani
Journal:  Hum Pathol       Date:  2004-03       Impact factor: 3.466

8.  Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis.

Authors:  Domenico Alvaro; Gianpiero Macarri; Maria Grazia Mancino; Marco Marzioni; MariaConsiglia Bragazzi; Paolo Onori; Stefano Ginanni Corradini; Pietro Invernizzi; Antonio Franchitto; Adolfo F Attili; Eugenio Gaudio; Antonio Benedetti
Journal:  Ann Intern Med       Date:  2007-10-02       Impact factor: 25.391

9.  Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.

Authors:  H A Pitt; A Nakeeb; R A Abrams; J Coleman; S Piantadosi; C J Yeo; K D Lillemore; J L Cameron
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

10.  Dose-additive carcinogenicity of a defined mixture of "dioxin-like compounds".

Authors:  Nigel J Walker; Patrick W Crockett; Abraham Nyska; Amy E Brix; Michael P Jokinen; Donald M Sells; James R Hailey; Micheal Easterling; Joseph K Haseman; Ming Yin; Michael E Wyde; John R Bucher; Christopher J Portier
Journal:  Environ Health Perspect       Date:  2005-01       Impact factor: 9.031

View more
  5 in total

1.  Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection.

Authors:  Zhiliang Wu; Thidarut Boonmars; Sirintip Boonjaraspinyo; Isao Nagano; Somchai Pinlaor; Anucha Puapairoj; Puangrat Yongvanit; Yuzo Takahashi
Journal:  Parasitol Res       Date:  2011-03-05       Impact factor: 2.289

Review 2.  Hilar cholangiocarcinoma: pathology and tumor biology.

Authors:  Dong Kuang; Guo-Ping Wang
Journal:  Front Med China       Date:  2010-11-25

3.  The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma.

Authors:  J Bart Rose; Camilo Correa-Gallego; Yu Li; James Nelson; Adnan Alseidi; W Scott Helton; Peter J Allen; Michael I D'Angelica; Ronald P DeMatteo; Yuman Fong; T Peter Kingham; Kris V Kowdley; William R Jarnagin; Flavio G Rocha
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

4.  The Diagnostic Roles of Cytokines in Hepatobiliary Cancers.

Authors:  Yavuz Savas Koca; Mahmut Bulbul; Ibrahim Barut
Journal:  Biomed Res Int       Date:  2017-12-19       Impact factor: 3.411

5.  Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.

Authors:  Zengwei Tang; Yuan Yang; Xiaolu Wang; Wenbo Meng; Xun Li
Journal:  BMJ Open       Date:  2019-01-29       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.